Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05909475
Other study ID # 22-022
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 4, 2022
Est. completion date December 24, 2022

Study information

Verified date June 2023
Source National Taiwan Sport University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Objective: To discuss the "GKEX Sports Probiotics Combination (hereinafter referred to as GKEX)", a product commissioned by Grape King Biotechnology Co., Ltd., and its effects on increasing muscle mass, muscle strength, physical performance and improving body composition when combined with resistance exercise training. Method: The experiment adopts a double-blind design. After screening, 52 subjects (20 males and 32 females) were randomly divided into two groups, each with 10 males and 16 females: (1) placebo without GKEX probiotics Capsule group (Placebo) (2 capsules/day), (2) GKEX group (GKEX) (1x1010 CFU/capsule, 2 capsules/day). All subjects received daily supplementation samples for 6 weeks and received resistance exercise training three times a week. Before the intervention and 6 weeks after the intervention, the diet evaluation, systemic and resistive body composition, muscle ultrasound, muscle strength, maximum oxygen uptake, explosive power, anaerobic power, etc. were detected respectively.


Recruitment information / eligibility

Status Completed
Enrollment 52
Est. completion date December 24, 2022
Est. primary completion date December 24, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 39 Years
Eligibility Inclusion Criteria: - The tissues and organs of the body are functioning normally - no disease, fatigue, or weakness - independent and flexible activities Exclusion Criteria: - With a history of cardiovascular disease, hypertension, metabolic disease, asthma or cancer diagnosed by a physician - BMI?27 - Who have taken anti-inflammatory analgesics or acute and chronic diseases within one month, etc., - The students and related stakeholders guided by the host of this plan - Who have the habit of smoking and drinking - Within two weeks Have used probiotic products in powder, capsule or tablet form (including yogurt, yogurt, Yakult and other related foods) - Food or allergic to lactic acid bacteria products - Have had hepatobiliary and gastrointestinal surgery within 2 years (except hernia and polypectomy)

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
GKEX
GKEX group. Probiotic capsules contain 10 billion CFU (colony forming units) of GKEX, , 2 caps daily use.
Other:
Placebo
The placebo capsule contains microcrystalline cellulose, 2 caps daily use.

Locations

Country Name City State
Taiwan Graduate Institute of Sports Science, National Taiwan Sport University Taoyuan

Sponsors (2)

Lead Sponsor Collaborator
National Taiwan Sport University Grape King Bio Ltd.

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Isometric Mid-Thigh Pull (IMTP_RFD Customized IMTP test equipment and two force plates (type 9287BA, Kistler Instruments AG, Winterthur, Switzerland) were used. All participants stood with their feet the same width apart, and the rod was placed between the thighs, with the torso upright, the spine neutral, and the knee and hip angles at 140°, to familiarize the participants with the IMPT test method. The average absolute peak rate of force development (RFD) parameters were recorded. up to 6 weeks
Primary Isometric Mid-Thigh Pull (IMTP)_relative peak force Customized IMTP test equipment and two force plates (type 9287BA, Kistler Instruments AG, Winterthur, Switzerland) were used. All participants stood with their feet the same width apart, and the rod was placed between the thighs, with the torso upright, the spine neutral, and the knee and hip angles at 140°, to familiarize the participants with the IMPT test method. The average absolute peak rate of force development (RFD) parameters were recorded. up to 6 weeks
Primary Wingate Anaerobic Test (WAnT)_relative peak power After a standard warm-up, all subjects were assessed with the classical WAnT on a cycloergometer (Monark 894E, Varberg, Sweden) in a 30 s "go all out" ultramax test. The seat height was adjusted to the satisfaction of each participant, and toe clips prevented the feet from slipping off the pedals. Before the initial test, the subjects warmed up for 5 min, and the power was approximately 50 W. After the warm-up, two preparation exercises lasting 3 s, during which the actual test load was 3% of their own body weight, were applied to accustom the participant to resistance. The test started, and the resistance was set on the friction belt of the dynamometer. External loading was estimated individually at 5% body weight. The average relative peak power parameters were recorded. up to 6 weeks
Primary Wingate Anaerobic Test (WAnT)_relative mean power After a standard warm-up, all subjects were assessed with the classical WAnT on a cycloergometer (Monark 894E, Varberg, Sweden) in a 30 s "go all out" ultramax test. The seat height was adjusted to the satisfaction of each participant, and toe clips prevented the feet from slipping off the pedals. Before the initial test, the subjects warmed up for 5 min, and the power was approximately 50 W. After the warm-up, two preparation exercises lasting 3 s, during which the actual test load was 3% of their own body weight, were applied to accustom the participant to resistance. The test started, and the resistance was set on the friction belt of the dynamometer. External loading was estimated individually at 5% body weight. The average relative mean power parameters were recorded. up to 6 weeks
Primary Wingate Anaerobic Test (WAnT)_fatigue index After a standard warm-up, all subjects were assessed with the classical WAnT on a cycloergometer (Monark 894E, Varberg, Sweden) in a 30 s "go all out" ultramax test. The seat height was adjusted to the satisfaction of each participant, and toe clips prevented the feet from slipping off the pedals. Before the initial test, the subjects warmed up for 5 min, and the power was approximately 50 W. After the warm-up, two preparation exercises lasting 3 s, during which the actual test load was 3% of their own body weight, were applied to accustom the participant to resistance. The test started, and the resistance was set on the friction belt of the dynamometer. External loading was estimated individually at 5% body weight. The average fatigue index parameters were recorded. up to 6 weeks
Primary The Countermovement Jump (CMJ) Test The CMJ test is a practical, effective, reliable, and simple method of measuring lower limb strength, which is related to the maximum speed, strength and explosive force of the lower limbs. For this test, participants stood on the Kistler force measurement platform (9260AA, Kistler Co., Ltd., Switzerland) on both feet and performed to inspection. During the test, they were asked to put their hands on their hips and remain on the platform. After that, they were asked to squat down until the knees bent 90 degrees and then to immediately jump as high as possible. The average power (MF), were recorded during the jump. Each participant repeated the test 3 times, and CMJ data were obtained at the designated points. The instrument was calibrated for each individual's weight. up to 6 weeks
Primary VO2max To evaluate the maximum oxygen consumption and exercise performance, we used a treadmill (Pulsar, h/p/cosmos, Nussdorf-Traunstein, Germany) and an automatic breathing analyzer (Vmax 29c, Sensor Medics, Yorba Linda, CA, USA). In addition, a polar heart rate device was used to monitor the heart rate (HR). The speed range of the treadmill was set to 7.2 km/h and increased by 1.8 km/h every 2 min until fatigue, according to Bruce's protocol. When the breathing exchange rate (the volume ratio of carbon dioxide produced to oxygen consumed, VCO2/VO2) was higher than 1.10 and reached the maximum heart rate (maximum heart rate = 220 - age), oxygen consumption was considered to be maximum. The three highest VO2max peak were averaged to obtain the VO2max values of the individual volunteers. up to 6 weeks
Primary Muscle composition_muscle thickness Use muscular ultrasound (BenQ T3300) to scan muscle thickness up to 6 weeks
Primary Muscle composition_fascia thickness Use muscular ultrasound (BenQ T3300) to scan fascia thickness up to 6 weeks
Primary dual-energy X-ray absorptiometry, DXA A non-invasive dual-energy X-ray absorptive bone density testing room (Lunar iDXA, GE Healthcare, Chicago, IL, USA) was used for systemic body composition and bone density measurements. The subject was required to lie flat on the test bed, with their body at the center line, and their limbs within the detection range. Two different energy X-rays were used to scan the inspected part, then the scintillation detector received the X-rays that had penetrated the inspected part, and analyzed the obtained muscle mass up to 6 weeks
Primary Body composition_body fat The multi-frequency principle was applied to measure body composition by using a bioelectrical impedance analyzer (BIA) on an InBody 570 device (In-body, Seoul, South Korea). To perform the measurements, after the subjects' palms and soles were removed from the sensors, the subjects stood on the footing electrodes and held the sensing handles with two hands. During the measurements, the subjects kept their arms open and left their bodies at an angle of 30° without speaking or moving. The subjects also fasted for at least 8 h before the test. The body fat were meansure up to 6 weeks
Primary Body composition_muscle mass The multi-frequency principle was applied to measure body composition by using a bioelectrical impedance analyzer (BIA) on an InBody 570 device (In-body, Seoul, South Korea). To perform the measurements, after the subjects' palms and soles were removed from the sensors, the subjects stood on the footing electrodes and held the sensing handles with two hands. During the measurements, the subjects kept their arms open and left their bodies at an angle of 30° without speaking or moving. The subjects also fasted for at least 8 h before the test. The muscle mass were meansure up to 6 weeks
Primary Grip strength Use the armed grip machine (T.K.K.5401, Takei Scientific Instruments Co.,Ltd, Niigata, Japan) to measure, hold each of the left and right hands three times until they are weak, and record the maximum value up to 6 weeks
Secondary Safety assessment - AST Safety is assessed function of liver such as AST (8-38 IU/L). up to 6 weeks
Secondary Safety assessment - ALT Safety is assessed function of liver such as ALT (4-44 IU/L). up to 6 weeks
Secondary Safety assessment - T-Cholesterol Safety is assessed function of blood lipid such as T-Cholesterol (<200 mg/dL). up to 6 weeks
Secondary Safety assessment - Uric Acid Safety is assessed function of kidney such as Uric Acid (3.4-7.6 mg/dl) up to 6 weeks
Secondary Safety assessment - BUN Safety is assessed function of kidney such as Bun (6-20 mg/dl) up to 6 weeks
Secondary Safety assessment - Creatinine Safety is assessed function of kidney such as Creatinine (0.6-1.3 mg/dl) up to 6 weeks
Secondary Safety assessment - Glucose Safety is assessed function of Glucose (70~100 mg/dL) up to 6 weeks
Secondary Safety assessment - Triglycerides Safety is assessed function of blood lipid such as Triglycerides (<150 mg/dL) up to 6 weeks
Secondary Safety assessment - LDL Safety is assessed function of blood lipid such as LDL (0~140mg/dl) up to 6 weeks
Secondary Safety assessment - HDL Safety is assessed function of blood lipid such as HDL (>40mg/dl) up to 6 weeks
See also
  Status Clinical Trial Phase
Completed NCT03219931 - NEOBIFI: Clinical Trial for the Prevention and/or Reduction of the Incidence of Colics in Infants Phase 4
Completed NCT05412667 - Investigation of TWK10 Administration on the Effects of Amino Acid Absorption N/A
Recruiting NCT05484128 - Lactobacillus Reuteri Strain Combination in Children Treated With PPI N/A
Active, not recruiting NCT04950803 - A Randomised-controlled Trial of an Oral Microbiome Immunity Formula in Recovered COVID-19 Patients N/A
Recruiting NCT06313346 - Effect of a Probiotic on Microbiota Associated With the Immune System and Inflammation. N/A
Recruiting NCT06231706 - ZOE BIOME Study: Biotics Influence on Microbiome Ecosystem N/A
Completed NCT03639337 - Colonization and Persistence Capacity of a Multi-strain Probiotics in Pediatric Food Allergy to Milk or Egg. N/A
Recruiting NCT06248177 - Probiotic Effect on Gastrointestinal Symptoms (FLORABIOTIC REFUERZO). N/A
Completed NCT03434860 - Effect of Probiotic on Insulin Resistance in Type 2 Diabetes Patients N/A
Completed NCT05374980 - The Effects of Yogurt on Gut Microbiome and Metabolism in H. Pylori. N/A
Not yet recruiting NCT05501470 - Probiotic For the Improvement of Environmental Enteropathy in Pregnant Women in Senegal Phase 2
Completed NCT03528707 - Effect of Probiotic Co-administration With Omega-3 Fatty Acids on NAFLD N/A
Recruiting NCT05548361 - The Use of Chlorhexidine and a Probiotic Lozenge in the Nonsurgical Therapy of Periodontitis N/A